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The role of selenium as a chemopreventive and chemotherapeutic agent has been supported by a 
large number of epidemiological, preclinical, and clinical trials [1, 2] suggesting that anti-tumor effect 
mechanisms of selenium include induction of apoptosis, inhibition of cell proliferation, protection 
against oxidative stress, and stimulation of immune system. 
Herein we demonstrate a simple and quick synthesis of uniform, stable, amorphous selenium 
nanoparticles (SeNps), using ascorbic acid as the reduction agent. The choice of an appropriate 
stabilizer and reducing agent for preparation of stable selenium nanoparticles is very important. We 
used bovine serum albumin (BSA) as an organic layer for selenium nanoparticles, i.e., as a capping 
agent to make them more biocompatibile and protect them from agglomeration in the suspension 
medium. 
SeNps were additionally encapsulated within spherical PLGA particles (PLGA/SeNps). One of the 
most important requirements for the controlled and balanced release of the drug in the body is ideal 
spherical shape of the particles and narrow distribution of their sizes. The morphology (size and 
shape) of the particles plays key role in their adhesion and interaction with the cell. 
The influence of PLGA/SeNps on cell viability, ROS generation in HepG2 cells, as well as 
anticancer activity against epithelial tumor cells was investigated. Synthesized nanoparticles were 
characterized by FTIR spectroscopy, FESEM, TEM, HRTEM, and Zeta potential measurements. As a 
part of this study, we have also performed in vivo dynamic imaging studies in normal mice, using 
SPECT imaging and a high resolution gamma camera. The PLGA/SeNps nanoparticles have been 
radiolabelled with Tc-99m, by applying the direct labeling method [3]. Ex vivo biodistribution 
measurements, as well as in vivo dynamic studies up to 1h p.i. and at 24h were performed, showing 
increased concentration in liver and spleen. 
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